On the computer screens, the mouse brain is shown from several angles. Then you click, and a small area of the brain is ...

A new study suggests that even modest amounts of this carbonated beverage may be associated with higher rates of metabolic fatty liver disease. A new study, published in the Annals of Hepatology, ...

ROCHESTER — Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in financing to advance its research and development. CEO Dr. John Swart ...

Subtle cellular interactions, especially involving immune cells and lipid metabolism, are crucial in MASH progression. A spatially resolved, multi-omics atlas of MASLD was developed, integrating ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Illumina became a genomics juggernaut by developing machines that could read large ...

Chronic liver disease gets worse when the liver's immune system stays overactive, resulting in ongoing inflammation and scarring. Signals from the gut make the situation worse by encouraging immune ...

From fast-food to ultra-processed snacks, a high-fat diet eaten over the long term may trigger biological changes in the liver that could raise the risk of cancer. Researchers from the Massachusetts ...

A combination of silybin and carvedilol is more effective than either drug alone for treating liver fibrosis, found a new study published in Targetome. Liver fibrosis is a chronic and multifactorial ...

Liver cells under chronic dietary stress essentially “forget” their normal jobs, shutting down essential functions to focus on bare survival. It’s a trade-off that creates cancer-prone conditions ...

Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a severe form of fatty liver disease in drug trials, the ...

The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...